JP2024506387A5 - - Google Patents

Info

Publication number
JP2024506387A5
JP2024506387A5 JP2023548877A JP2023548877A JP2024506387A5 JP 2024506387 A5 JP2024506387 A5 JP 2024506387A5 JP 2023548877 A JP2023548877 A JP 2023548877A JP 2023548877 A JP2023548877 A JP 2023548877A JP 2024506387 A5 JP2024506387 A5 JP 2024506387A5
Authority
JP
Japan
Prior art keywords
compound according
hydrogen
amino
pharmaceutical composition
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023548877A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024506387A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/015767 external-priority patent/WO2022173795A1/en
Publication of JP2024506387A publication Critical patent/JP2024506387A/ja
Publication of JP2024506387A5 publication Critical patent/JP2024506387A5/ja
Pending legal-status Critical Current

Links

JP2023548877A 2021-02-10 2022-02-09 腎線維症を治療するためのオキサジアゾリルジヒドロピラノ[2,3‐b]ピリジン系HIPK2阻害剤 Pending JP2024506387A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163147859P 2021-02-10 2021-02-10
US63/147,859 2021-02-10
PCT/US2022/015767 WO2022173795A1 (en) 2021-02-10 2022-02-09 OXADIAZOLYL DIHYDROPYRANO[2,3-b]PYRIDINE INHIBITORS OF HIPK2 FOR TREATING KIDNEY FIBROSIS

Publications (2)

Publication Number Publication Date
JP2024506387A JP2024506387A (ja) 2024-02-13
JP2024506387A5 true JP2024506387A5 (https=) 2025-01-27

Family

ID=82837244

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023548877A Pending JP2024506387A (ja) 2021-02-10 2022-02-09 腎線維症を治療するためのオキサジアゾリルジヒドロピラノ[2,3‐b]ピリジン系HIPK2阻害剤

Country Status (9)

Country Link
US (1) US20250179084A1 (https=)
EP (1) EP4291183B1 (https=)
JP (1) JP2024506387A (https=)
KR (1) KR20230154194A (https=)
CN (1) CN117479934A (https=)
AU (1) AU2022221336A1 (https=)
CA (1) CA3210658A1 (https=)
MX (1) MX2023009323A (https=)
WO (1) WO2022173795A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240051965A1 (en) * 2022-08-05 2024-02-15 Icahn School Of Medicine At Mount Sinai Oxygen-containing heterocyclic compound and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2069335T3 (pl) * 2006-09-08 2013-05-31 Actelion Pharmaceuticals Ltd Pochodne pirydyn-3-ylu jako środki immunomodulujące
PE20091339A1 (es) * 2007-12-21 2009-09-26 Glaxo Group Ltd Derivados de oxadiazol con actividad sobre receptores s1p1
EP2210890A1 (en) * 2009-01-19 2010-07-28 Almirall, S.A. Oxadiazole derivatives as S1P1 receptor agonists
ES2907624T3 (es) * 2017-01-06 2022-04-25 Icahn School Med Mount Sinai Inhibidores de oxadiazol de HIPK2 para el tratamiento de la fibrosis renal
JP7252908B2 (ja) * 2017-06-14 2023-04-05 トレベナ・インコーポレイテッド S1p1活性を調節するための化合物およびその使用法

Similar Documents

Publication Publication Date Title
AU2008247102B2 (en) 2 -pyridine carboxamide derivatives as sodium channel modulators
KR910007970B1 (ko) 4h-1-벤조피란-4-온 유도체 또는 이의 염, 이의 제조방법 및 활성 성분으로서 이를 함유하는 약제학적 조성물
ES2325045T3 (es) Nuevos derivados de pirazol heterociclilmetil sustituidos y su uso en el tratamiento de enfermedades cardiovasculares.
CA2402549A1 (en) Substituted beta-carbolines
WO2022194066A1 (zh) Kras g12d抑制剂及其在医药上的应用
TW202224675A (zh) 含有ep拮抗藥與免疫核查點阻礙藥而成之組合的用途
KR20030014206A (ko) 이미다조피리딘 유도체
WO2007032466A1 (ja) 複素環化合物、その製造方法並びに用途
CA2741839A1 (en) 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors
RS66963B1 (sr) 1,2-naftohinonski derivat i postupak za njegovu pripremu
WO2014203217A1 (en) Substituted heterocyclic compounds as crac modulators
JP2020502123A (ja) Nrf2アクチベーターとしてのビスアリール複素環
JP2024521141A (ja) Kat6a阻害剤としての縮合イソオキサゾリル化合物
WO2019062328A1 (zh) 苯胺取代的1,2-二氢吡咯并[3,4-c]吡啶/嘧啶-3-酮衍生物及用途
JP7389238B2 (ja) ピリミジン化合物及びその調製方法
WO2019144764A1 (zh) 芳香杂环化合物、其中间体、制备方法、药物组合物和应用
WO2015064714A1 (ja) オートタキシン阻害活性を有する1-置換イミダゾピリミジノン誘導体
RU2721120C2 (ru) Новые гетероциклические соединения как ингибиторы brd4
WO2020143385A1 (zh) 芳基酰胺类抑制剂及其制备方法和应用
WO2015092118A1 (en) Spiro[cyclobutane-1,3'-indolin]-2'-one derivatives as bromodomain inhibitors
JP2024506387A5 (https=)
JP2008515980A (ja) 閉塞性動脈疾患のためのアリールスルホンアミドぺリ置換二環式化合物
JP2010524913A (ja) 炎症治療において有用なピラゾール
JP2016164154A (ja) オートタキシン阻害活性を有する7位無置換縮合ピラゾール誘導体
CN110437235B (zh) 3-酰胺氮杂吲哚类化合物作为肥大细胞调节剂及其制备方法和用途